Study: Questions raised on profit-backed clinical trials

05/16/2006 | United Press International

A study in today's issue of the Journal of the American Medical Association found 67% of cardiovascular clinical trials backed by for-profit groups favored newer treatments while only 49% did so among nonprofit-backed trials. While it adds fuel to the argument that the objectivity of researchers is affected by financial ties to drug companies, the authors say there may be other explanations for the results.

View Full Article in:

United Press International

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Chief, Product Review Branch
FDA/Center for Biologics Evaluation and Research
Silver Spring, MD
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ